Genetic Variants of Nogo-66 Receptor with Possible Association to Schizophrenia Block Myelin Inhibition of Axon Growth

This work was supported in part by grants from the National Institutes of Health and the Falk Medical Research Trust (S.M.S.) and a Scottish Rite fellowship (S.B.). S.M.S. and A.F.T.A. are members of the Kavli Institute of Neuroscience at Yale. We acknowledge that data and biomaterials were collected in three projects that participated in the National Institute of Mental Health Schizophrenia Genetics Initiative. From 1991 to 1997, the principal investigators and coinvestigators were as follows: Harvard University (Boston, MA) (Grant U01 MH46318), Ming T. Tsuang, MD, PhD, DSc, Stephen Faraone, PhD, and John Pepple, PhD; Washington University (St. Louis, MO) (Grant U01 MH46276), C. Robert Cloninger, MD, Theodore Reich, MD, and Dragan Svrakic, MD; and Columbia University (New York, NY) (Grant U01 MH46289), Charles Kaufmann, MD, Dolores Malaspina, MD, and Jill Harkavy Friedman, PhD.